SocialBookmarkLink.com

  • Submit Story
  • Popular Stories
  • Login
Trending now

Sorry, no trending stories at the moment.

Tory leadership contender Robert Jenrick took weight loss drug Ozempic but ‘didn’t enjoy it’ | Business News

1
newsgravity newsgravity 2 years ago in Business 0

Reliable. Secure. Since 2012. Exchange Crypto Sign up to get a trading fee discount!


Buy/Sell Crypto on best exchanges Binance, Bybit, Coinbase, Gemini, HTX, KuCoin, MEXC, Poloniex

Tory leadership hopeful Robert Jenrick has admitted to using the weight loss jab Ozempic but said he “didn’t particularly enjoy it”.

The former immigration minister confirmed he took the medication for around six weeks last autumn to slim down.

Politics live: Govt under fire over airport decision

He said it was “helpful” but he has since focused on losing weight “in the normal way” by eating healthier food and exercising more.

“To be honest, I was overweight,” Mr Jenrick told Politico.

“I took Ozempic for a short period of time, didn’t particularly enjoy it, but it was helpful.

“Since then, I’ve just lost weight in the normal way by eating less, eating more healthily, doing some exercise – going to the gym, going running. I’ve lost four stone in 12 months.”

Mr Jenrick was addressing rumours about his sudden weight loss since leaving government.

He resigned as immigration minister in December over Rishi Sunak’s failure to get the Rwanda asylum scheme up and running.

He is now vying to replace the former prime minister as Tory leader following the party’s hammering at the general election.

Read more: Who is running to replace Sunak as Tory leader?

Immigration Minister Robert Jenrick reportedly felt the mural gave the impression the UK was 'welcoming' to asylum seekers crossing the Channel
Image:
Mr Jenrick used the drug for six weeks last autumn. The then immigration minister, pictured in 2023. Pic: PA

Another leadership contender, Tom Tugendhat, recently denied using the medication but said he had been off booze for a year and was under instruction from his wife to “stay off bread and potatoes” in a bid to get lean.

Ozempic, a weekly injection initially designed to treat type 2 diabetes, has been touted by celebrities and social media influencers as a “miracle drug” for weight loss.

Delivered via an injection into the skin, the drug makes people feel fuller and more satisfied, so they eat less.

Last year, former prime minister Boris Johnson revealed he had taken the medication to stop his late-night “cheddar and chorizo” fridge raids, after noticing colleagues had shed some weight because of the drug.

“For weeks I jabbed my stomach, and for weeks it worked,” he wrote in his Daily Mail column.

“Effortlessly, I pushed aside the puddings and the second helpings. I must have been losing four or five pounds a week – maybe more.”

However, Mr Johnson said he eventually stopped taking Ozempic due to side effects (which can commonly include nausea, diarrhoea and vomiting), though he didn’t go into detail about what those were.

Read more from Sky News:
What are the weight loss injections?
Stephen Fry reveals weight-loss drug made him vomit

Is Ozempic available on the NHS?

Please use Chrome browser for a more accessible video player


What is the weight loss drug semaglutide?

4:44

New weight loss drugs explained

Ozempic is only available on the NHS for people with type two diabetes.

Last year Wegovy, which has the same active ingredient (semaglutide), was given the green light to be prescribed for weight loss with strict criteria around who can get the drugs.

Pharmacists have reported a shortage of the drug because of its sudden surge in popularity – plus the fact some medics are prescribing it off-label for obese people.

This has led to those with diabetes finding it more difficult to access, while also fuelling a rise in counterfeit jabs.

Professor Stephen Powis, NHS England’s national medical director, has recently expressed alarm at people misusing the drug as a “quick fix” to “lose a few pounds”, saying they should only be taken with medial supervision.


Source link
#Tory #leadership #contender #Robert #Jenrick #weight #loss #drug #Ozempic #didnt #enjoy #Business #News

  • Facebook
  • Twitter
  • Pinterest
Report Story

Related Stories

  1. Mobile Repair in Kolkata
  2. Marine Cable Suppliers Supporting Marine Infrastructure Projects in the UAE
  3. German media giant Axel Springer to buy Telegraph Media Group...
  4. Heating and Air Service
Tags : Business, contender, Didnt, drug, enjoy, Jenrick, leadership, loss, News, Ozempic, Robert, Tory, weight

Story Categories

  • Automotive
  • Business
    • Accounting
    • Advertising & Marketing
    • Construction
    • E-Commerce
    • Industrial
    • Investing
    • Real Estate
  • Education
  • Entertainment
  • Health
  • Internet
    • Social Media
    • Web Design
    • Web Development
    • Web Hosting
  • News
  • Science
  • Shopping
    • Clothing
    • Coupons
    • Electronics
    • Home & Garden
    • Jewelry
  • Technology
  • Travel
    • Business Travel

Popular Stories

  • Mobile Repair in Kolkata

    Mobile Repair in Kolkata rebootit.in

  • Marine Cable Suppliers Supporting Marine Infrastructure Projects in the UAE

    Marine Cable Suppliers Supporting Marine Infrastructure Projects in the UAE oceanicgms.com

  • The Symbolism Behind Pink Flowers: Love, Grace & Gentle Emotion

    The Symbolism Behind Pink Flowers: Love, Grace & Gentle Emotion 1magnolialane.com

  • German media giant Axel Springer to buy Telegraph Media Group in £575m deal | Money News

    German media giant Axel Springer to buy Telegraph Media Group in £575m deal | Money News

  • Metakaolin Market 2025-2032: Growth Analysis, Key Players, Innovations, and Regional Outlook

    Metakaolin Market 2025-2032: Growth Analysis, Key Players, Innovations, and Regional Outlook intelmarketresearch.com

  • FPC Market to Reach USD 17,860 Million by 2032, Growing at 3.6% CAGR

    FPC Market to Reach USD 17,860 Million by 2032, Growing at 3.6% CAGR semiconductorinsight.com

  • Growing Adoption of Game Cameras Strengthens Market Outlook Worldwide

    Growing Adoption of Game Cameras Strengthens Market Outlook Worldwide semiconductorinsight.com

  • Heating and Air Service

    Heating and Air Service anytimeserviceguys.com

  • Global Lyocell Fiber Market to Reach USD 1.47 Billion by 2032, Growing at a CAGR of 9.3%

    Global Lyocell Fiber Market to Reach USD 1.47 Billion by 2032, Growing at a CAGR of 9.3% intelmarketresearch.com

  • Global Coronary Atherectomy Devices Market to Reach USD 402 Million by 2032, Growing at a CAGR of 7.1%

    Global Coronary Atherectomy Devices Market to Reach USD 402 Million by 2032, Growing at a CAGR of 7.1% intelmarketresearch.com

  • Social Bookmark Link
  • Privacy Policy
  • Content Policy
  • Contact
Copyright SocialBookmarkLink.com 2026. All Rights Reserved
Login Register

Login

Lost Password

Register

Lost Password